Clinical Drug Experience Knowledgebase

betamethasone (celestone) (2 trials)

deng zhan sheng mai (1 trial)

dydrogesterone (gynorest) (1 trial)

eltrombopag (promacta) (1 trial)

estradiol (progynon depot) (1 trial)

hydroquinone (1 trial)

kuntai (1 trial)

methylprednisolone (medrol) (1 trial)

musk (1 trial)

rituximab (rituxan) (1 trial)

ropivacaine (naropin) (3 trials)

sodium chloride (1 trial)

somatropin (protropin) (1 trial)

valsartan (diovan) (1 trial)

cetuximab (erbitux) (1 trial)

dexamethasone (1 trial)

huachansu pian (1 trial)

icaritin (2 trials)

irinotecan (Camptosar) (1 trial)

ranibizumab (lucentis) (1 trial)

sorafenib (nexavar) (1 trial)

abiraterone (zytiga) (1 trial)

azacitidine (vidaza) (2 trials)

cisplatin (platinol) (1 trial)

cladribine (leustatin) (2 trials)

cyclophosphamide (cytoxan) (1 trial)

cytarabine (cytosar-u) (2 trials)

epirubicin (ellence) (1 trial)

f-627 (1 trial)

fluorouracil (efudex) (1 trial)

genakumab (1 trial)

prednisone (meticorten) (1 trial)

sargramostim (leukine) (1 trial)

venetoclax (venclexta) (4 trials)

hcd19.il15.car-inkt (1 trial)

platelet rich plasma (1 trial)

tang ning tongluo (1 trial)

anlotinib (1 trial)

gefitinib (iressa) (1 trial)

icotinib (1 trial)

lidocaine (xylocaine) (1 trial)

resveratrol (1 trial)

vitamin e (1 trial)

xingnaojing (1 trial)